Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Perissodactyla; Equidae; Equus; Equus,
Latin Name:
Equus caballus
Tested tissues: PBMC,
Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
---|---|---|---|---|---|---|
Vthunter_0066 | 2021.04 | iDrop | PBMC | Normal | 12794 | Link |
Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
---|---|---|
![]() |
Venezuelan equine encephalitis virus |
PBMC-T cells : 90.44% ; PBMC-NK : 86.96% ; PBMC-B cells : 84.24% ; PBMC-Macrophage : 83.72% ; PBMC-Cycling_T : 52.38% ; |
![]() |
Sindbis virus |
PBMC-T cells : 90.44% ; PBMC-NK : 86.96% ; PBMC-B cells : 84.24% ; PBMC-Macrophage : 83.72% ; PBMC-Cycling_T : 52.38% ; |
![]() |
Adeno-associated virus - 2 |
PBMC-T cells : 90.44% ; PBMC-NK : 86.96% ; PBMC-B cells : 84.24% ; PBMC-Macrophage : 83.72% ; PBMC-Cycling_T : 52.38% ; PBMC-Macrophage : 43.02% ; PBMC-NK : 42.03% ; PBMC-T cells : 29.22% ; PBMC-Cycling_T : 20.63% ; PBMC-B cells : 17.50% ; PBMC-NK : 8.70% ; PBMC-T cells : 6.19% ; PBMC-B cells : 3.87% ; PBMC-Macrophage : 2.91% ; PBMC-Neutrophil : 1.43% ; PBMC-NK : 7.25% ; PBMC-B cells : 5.71% ; PBMC-Macrophage : 5.23% ; PBMC-T cells : 4.87% ; PBMC-Cycling_T : 1.59% ; |
![]() |
Adeno-associated virus 9 |
PBMC-T cells : 90.44% ; PBMC-NK : 86.96% ; PBMC-B cells : 84.24% ; PBMC-Macrophage : 83.72% ; PBMC-Cycling_T : 52.38% ; |
![]() |
Dengue virus |
PBMC-T cells : 90.44% ; PBMC-NK : 86.96% ; PBMC-B cells : 84.24% ; PBMC-Macrophage : 83.72% ; PBMC-Cycling_T : 52.38% ; PBMC-Macrophage : 6.40% ; PBMC-Neutrophil : 0.52% ; PBMC-T cells : 0.12% ; PBMC-B cells : 0.10% ; PBMC-T cells : 0.36% ; PBMC-NK : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Neutrophil : 0.00% ; |
![]() |
Adeno-associated virus - 8 |
PBMC-T cells : 90.44% ; PBMC-NK : 86.96% ; PBMC-B cells : 84.24% ; PBMC-Macrophage : 83.72% ; PBMC-Cycling_T : 52.38% ; |
![]() |
Classical swine fever virus |
PBMC-T cells : 90.44% ; PBMC-NK : 86.96% ; PBMC-B cells : 84.24% ; PBMC-Macrophage : 83.72% ; PBMC-Cycling_T : 52.38% ; |
![]() |
Adeno-associated virus - 3 |
PBMC-T cells : 90.44% ; PBMC-NK : 86.96% ; PBMC-B cells : 84.24% ; PBMC-Macrophage : 83.72% ; PBMC-Cycling_T : 52.38% ; |
![]() |
Feline immunodeficiency virus | |
![]() |
Human immunodeficiency virus 2 | |
![]() |
Human immunodeficiency virus 1 |
PBMC-T cells : 87.13% ; PBMC-Macrophage : 84.88% ; PBMC-NK : 68.12% ; PBMC-B cells : 53.09% ; PBMC-Neutrophil : 48.52% ; PBMC-T cells : 18.76% ; PBMC-Macrophage : 18.60% ; PBMC-Cycling_T : 6.35% ; PBMC-B cells : 1.45% ; PBMC-NK : 1.45% ; PBMC-NK : 8.70% ; PBMC-Macrophage : 6.40% ; PBMC-T cells : 5.29% ; PBMC-Cycling_T : 3.17% ; PBMC-B cells : 1.55% ; |
![]() |
Influenza A virus |
PBMC-Macrophage : 82.56% ; PBMC-Neutrophil : 51.48% ; PBMC-B cells : 16.44% ; PBMC-Cycling_T : 15.87% ; PBMC-T cells : 13.05% ; PBMC-Macrophage : 21.51% ; PBMC-B cells : 20.12% ; PBMC-NK : 15.94% ; PBMC-T cells : 8.96% ; PBMC-Cycling_T : 6.35% ; PBMC-Macrophage : 0.58% ; PBMC-T cells : 0.12% ; PBMC-B cells : 0.10% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Lassa mammarenavirus |
PBMC-Macrophage : 79.65% ; PBMC-NK : 33.33% ; PBMC-T cells : 33.25% ; PBMC-B cells : 31.91% ; PBMC-Cycling_T : 22.22% ; PBMC-Cycling_T : 4.76% ; PBMC-NK : 4.35% ; PBMC-T cells : 3.61% ; PBMC-B cells : 2.22% ; PBMC-Macrophage : 1.16% ; PBMC-T cells : 0.36% ; PBMC-Neutrophil : 0.00% ; PBMC-NK : 0.00% ; PBMC-B cells : 0.00% ; |
![]() |
Simian rotavirus A strain RRV |
PBMC-NK : 76.81% ; PBMC-Macrophage : 73.26% ; PBMC-T cells : 72.58% ; PBMC-B cells : 67.02% ; PBMC-Cycling_T : 46.03% ; PBMC-Macrophage : 43.02% ; PBMC-NK : 42.03% ; PBMC-T cells : 29.22% ; PBMC-Cycling_T : 20.63% ; PBMC-B cells : 17.50% ; PBMC-Macrophage : 9.30% ; PBMC-T cells : 8.42% ; PBMC-NK : 7.25% ; PBMC-B cells : 1.35% ; PBMC-Neutrophil : 0.62% ; PBMC-Macrophage : 7.56% ; PBMC-Cycling_T : 3.17% ; PBMC-T cells : 0.78% ; PBMC-B cells : 0.19% ; PBMC-Neutrophil : 0.05% ; PBMC-T cells : 2.04% ; PBMC-NK : 1.45% ; PBMC-B cells : 0.19% ; PBMC-Neutrophil : 0.05% ; PBMC-Cycling_T : 0.00% ; PBMC-T cells : 0.96% ; PBMC-Macrophage : 0.58% ; PBMC-Neutrophil : 0.14% ; PBMC-B cells : 0.10% ; PBMC-NK : 0.00% ; |
![]() |
Human alphaherpesvirus 2 |
PBMC-Macrophage : 57.56% ; PBMC-T cells : 27.00% ; PBMC-Neutrophil : 22.28% ; PBMC-NK : 21.74% ; PBMC-Cycling_T : 17.46% ; PBMC-Macrophage : 1.74% ; PBMC-Neutrophil : 0.38% ; PBMC-B cells : 0.10% ; PBMC-T cells : 0.06% ; PBMC-B cells : 0.19% ; PBMC-T cells : 0.06% ; PBMC-NK : 0.00% ; PBMC-Neutrophil : 0.00% ; |
![]() |
Human alphaherpesvirus 1 |
PBMC-Macrophage : 57.56% ; PBMC-T cells : 27.00% ; PBMC-Neutrophil : 22.28% ; PBMC-NK : 21.74% ; PBMC-Cycling_T : 17.46% ; PBMC-Macrophage : 9.30% ; PBMC-T cells : 8.42% ; PBMC-NK : 7.25% ; PBMC-B cells : 1.35% ; PBMC-Neutrophil : 0.62% ; PBMC-Macrophage : 1.74% ; PBMC-Neutrophil : 0.38% ; PBMC-B cells : 0.10% ; PBMC-T cells : 0.06% ; PBMC-Cycling_T : 0.00% ; PBMC-B cells : 0.19% ; PBMC-T cells : 0.06% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Rhinovirus B14 |
PBMC-Macrophage : 56.98% ; PBMC-Neutrophil : 5.92% ; PBMC-B cells : 2.80% ; PBMC-T cells : 1.92% ; PBMC-NK : 1.45% ; |
![]() |
Coxsackievirus A21 | |
![]() |
Ebola virus |
PBMC-B cells : 55.51% ; PBMC-Macrophage : 23.84% ; PBMC-Cycling_T : 9.52% ; PBMC-T cells : 8.90% ; PBMC-NK : 8.70% ; PBMC-Macrophage : 4.65% ; PBMC-Neutrophil : 0.72% ; PBMC-B cells : 0.68% ; PBMC-T cells : 0.12% ; PBMC-T cells : 0.36% ; PBMC-B cells : 0.00% ; PBMC-Neutrophil : 0.00% ; |
![]() |
Hepacivirus C |
PBMC-Macrophage : 52.91% ; PBMC-B cells : 33.17% ; PBMC-NK : 30.43% ; PBMC-T cells : 29.10% ; PBMC-Cycling_T : 7.94% ; PBMC-Macrophage : 50.58% ; PBMC-Neutrophil : 17.18% ; PBMC-NK : 11.59% ; PBMC-Cycling_T : 7.94% ; PBMC-T cells : 6.19% ; PBMC-Macrophage : 36.63% ; PBMC-Cycling_T : 6.35% ; PBMC-B cells : 4.93% ; PBMC-T cells : 3.73% ; PBMC-NK : 2.90% ; PBMC-Macrophage : 23.84% ; PBMC-B cells : 20.31% ; PBMC-Cycling_T : 7.94% ; PBMC-T cells : 7.82% ; PBMC-NK : 7.25% ; PBMC-B cells : 0.77% ; PBMC-Macrophage : 0.58% ; PBMC-T cells : 0.24% ; PBMC-B cells : 0.29% ; PBMC-T cells : 0.12% ; PBMC-Cycling_T : 0.00% ; PBMC-Macrophage : 0.00% ; |
![]() |
Vesicular stomatitis virus | |
![]() |
Human rhinovirus A2 |
PBMC-Macrophage : 50.58% ; PBMC-Neutrophil : 17.18% ; PBMC-NK : 11.59% ; PBMC-Cycling_T : 7.94% ; PBMC-T cells : 6.19% ; |
![]() |
Equid alphaherpesvirus 1 | |
![]() |
Gibbon ape leukemia virus | |
![]() |
Simian sarcoma-associated virus |
PBMC-Macrophage : 48.84% ; PBMC-B cells : 34.43% ; PBMC-T cells : 23.09% ; PBMC-NK : 20.29% ; PBMC-Cycling_T : 15.87% ; |
![]() |
Feline leukemia virus strain B/lambda-B1 | |
![]() |
Human mastadenovirus B | |
![]() |
Human betaherpesvirus 5 |
PBMC-Macrophage : 43.02% ; PBMC-NK : 42.03% ; PBMC-T cells : 29.22% ; PBMC-Cycling_T : 20.63% ; PBMC-B cells : 17.50% ; PBMC-Macrophage : 9.30% ; PBMC-T cells : 8.42% ; PBMC-NK : 7.25% ; PBMC-B cells : 1.35% ; PBMC-Neutrophil : 0.62% ; PBMC-T cells : 0.96% ; PBMC-Macrophage : 0.58% ; PBMC-Neutrophil : 0.14% ; PBMC-B cells : 0.10% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Human parvovirus B19 | |
![]() |
Mammalian orthoreovirus | |
![]() |
Human metapneumovirus | |
![]() |
Echovirus E8 | |
![]() |
Human gammaherpesvirus 4 |
PBMC-Macrophage : 43.02% ; PBMC-NK : 42.03% ; PBMC-T cells : 29.22% ; PBMC-Cycling_T : 20.63% ; PBMC-B cells : 17.50% ; |
![]() |
Human rotavirus strain WA |
PBMC-Macrophage : 43.02% ; PBMC-NK : 42.03% ; PBMC-T cells : 29.22% ; PBMC-Cycling_T : 20.63% ; PBMC-B cells : 17.50% ; PBMC-Macrophage : 7.56% ; PBMC-Cycling_T : 3.17% ; PBMC-T cells : 0.78% ; PBMC-B cells : 0.19% ; PBMC-Neutrophil : 0.05% ; PBMC-T cells : 2.04% ; PBMC-NK : 1.45% ; PBMC-B cells : 0.19% ; PBMC-Neutrophil : 0.05% ; |
![]() |
Echovirus E1 | |
![]() |
Foot-and-mouth disease virus |
PBMC-Macrophage : 43.02% ; PBMC-NK : 42.03% ; PBMC-T cells : 29.22% ; PBMC-Cycling_T : 20.63% ; PBMC-B cells : 17.50% ; PBMC-Macrophage : 9.30% ; PBMC-T cells : 8.42% ; PBMC-NK : 7.25% ; PBMC-B cells : 1.35% ; PBMC-Neutrophil : 0.62% ; PBMC-NK : 8.70% ; PBMC-T cells : 6.19% ; PBMC-B cells : 3.87% ; PBMC-Macrophage : 2.91% ; PBMC-Neutrophil : 1.43% ; PBMC-T cells : 0.96% ; PBMC-Macrophage : 0.58% ; PBMC-Neutrophil : 0.14% ; PBMC-B cells : 0.10% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Bovine leukemia virus |
PBMC-Macrophage : 41.86% ; PBMC-B cells : 25.73% ; PBMC-Cycling_T : 25.40% ; PBMC-T cells : 23.93% ; PBMC-NK : 20.29% ; |
![]() |
Machupo mammarenavirus |
PBMC-Macrophage : 36.63% ; PBMC-Cycling_T : 6.35% ; PBMC-B cells : 4.93% ; PBMC-T cells : 3.73% ; PBMC-NK : 2.90% ; |
![]() |
Mouse mammary tumor virus |
PBMC-Macrophage : 36.63% ; PBMC-Cycling_T : 6.35% ; PBMC-B cells : 4.93% ; PBMC-T cells : 3.73% ; PBMC-NK : 2.90% ; |
![]() |
Canine parvovirus |
PBMC-Macrophage : 36.63% ; PBMC-Cycling_T : 6.35% ; PBMC-B cells : 4.93% ; PBMC-T cells : 3.73% ; PBMC-NK : 2.90% ; |
![]() |
Argentinian mammarenavirus |
PBMC-Macrophage : 36.63% ; PBMC-Cycling_T : 6.35% ; PBMC-B cells : 4.93% ; PBMC-T cells : 3.73% ; PBMC-NK : 2.90% ; |
![]() |
Feline panleukopenia virus |
PBMC-Macrophage : 36.63% ; PBMC-Cycling_T : 6.35% ; PBMC-B cells : 4.93% ; PBMC-T cells : 3.73% ; PBMC-NK : 2.90% ; |
![]() |
Severe acute respiratory syndrome coronavirus 2 | |
![]() |
Guanarito mammarenavirus |
PBMC-Macrophage : 36.63% ; PBMC-Cycling_T : 6.35% ; PBMC-B cells : 4.93% ; PBMC-T cells : 3.73% ; PBMC-NK : 2.90% ; |
![]() |
Feline endogenous virus RD114 |
PBMC-Macrophage : 30.81% ; PBMC-B cells : 27.95% ; PBMC-Cycling_T : 6.35% ; PBMC-NK : 4.35% ; PBMC-T cells : 3.67% ; |
![]() |
Simian type D retrovirus -Tsukuba |
PBMC-Macrophage : 30.81% ; PBMC-B cells : 27.95% ; PBMC-Cycling_T : 6.35% ; PBMC-NK : 4.35% ; PBMC-T cells : 3.67% ; |
![]() |
Baboon endogenous virus strain M7 |
PBMC-Macrophage : 30.81% ; PBMC-B cells : 27.95% ; PBMC-Cycling_T : 6.35% ; PBMC-NK : 4.35% ; PBMC-T cells : 3.67% ; |
![]() |
Enterovirus A71 | |
![]() |
Coxsackievirus A16 |
PBMC-NK : 27.54% ; PBMC-Macrophage : 18.02% ; PBMC-T cells : 9.56% ; PBMC-Cycling_T : 6.35% ; PBMC-B cells : 4.26% ; |
![]() |
Human betaherpesvirus 6B |
PBMC-T cells : 22.97% ; PBMC-Macrophage : 19.19% ; PBMC-NK : 8.70% ; PBMC-Cycling_T : 7.94% ; PBMC-B cells : 1.84% ; |
![]() |
Feline leukemia virus strain C/FA27 |
PBMC-B cells : 22.15% ; PBMC-Macrophage : 16.86% ; PBMC-T cells : 9.68% ; PBMC-NK : 8.70% ; PBMC-Cycling_T : 7.94% ; |
![]() |
Enterovirus B |
PBMC-Macrophage : 22.09% ; PBMC-T cells : 1.68% ; PBMC-Cycling_T : 1.59% ; PBMC-NK : 1.45% ; PBMC-B cells : 0.77% ; |
![]() |
Porcine endogenous retrovirus A |
PBMC-NK : 20.29% ; PBMC-Cycling_T : 15.87% ; PBMC-T cells : 8.12% ; PBMC-Macrophage : 7.56% ; PBMC-B cells : 5.03% ; |
![]() |
Simian immunodeficiency virus | |
![]() |
Human betaherpesvirus 7 |
PBMC-T cells : 18.76% ; PBMC-Macrophage : 18.60% ; PBMC-Cycling_T : 6.35% ; PBMC-B cells : 1.45% ; PBMC-NK : 1.45% ; |
![]() |
Porcine reproductive and respiratory syndrome virus | |
![]() |
Human papillomavirus type 16 | |
![]() |
Xenotropic murine leukemia virus |
PBMC-Macrophage : 14.53% ; PBMC-B cells : 7.06% ; PBMC-Cycling_T : 6.35% ; PBMC-T cells : 5.23% ; PBMC-NK : 1.45% ; |
![]() |
Polytropic murine leukemia virus |
PBMC-Macrophage : 14.53% ; PBMC-B cells : 7.06% ; PBMC-Cycling_T : 6.35% ; PBMC-T cells : 5.23% ; PBMC-NK : 1.45% ; |
![]() |
Ecotropic murine leukemia virus |
PBMC-Macrophage : 13.95% ; PBMC-B cells : 9.19% ; PBMC-NK : 5.80% ; PBMC-T cells : 1.86% ; PBMC-Cycling_T : 1.59% ; |
![]() |
Human alphaherpesvirus 3 |
PBMC-NK : 13.04% ; PBMC-B cells : 12.67% ; PBMC-Cycling_T : 9.52% ; PBMC-Macrophage : 6.98% ; PBMC-T cells : 5.89% ; |
![]() |
Varicella Zoster Virus |
PBMC-NK : 13.04% ; PBMC-B cells : 12.67% ; PBMC-Cycling_T : 9.52% ; PBMC-Macrophage : 6.98% ; PBMC-T cells : 5.89% ; |
![]() |
Bovine alphaherpesvirus 1 | |
![]() |
Enterovirus C |
PBMC-Macrophage : 12.21% ; PBMC-B cells : 0.19% ; PBMC-T cells : 0.18% ; PBMC-Neutrophil : 0.05% ; PBMC-NK : 0.00% ; |
![]() |
Suid alphaherpesvirus 1 |
PBMC-Macrophage : 12.21% ; PBMC-B cells : 0.19% ; PBMC-T cells : 0.18% ; PBMC-Neutrophil : 0.05% ; PBMC-NK : 0.00% ; PBMC-Macrophage : 1.74% ; PBMC-Neutrophil : 0.38% ; PBMC-B cells : 0.10% ; PBMC-T cells : 0.06% ; PBMC-B cells : 0.19% ; PBMC-T cells : 0.06% ; PBMC-Neutrophil : 0.00% ; |
![]() |
Middle East respiratory syndrome-related coronavirus |
PBMC-T cells : 11.43% ; PBMC-NK : 8.70% ; PBMC-Cycling_T : 7.94% ; PBMC-Macrophage : 5.81% ; PBMC-B cells : 4.84% ; |
![]() |
Chikungunya virus | |
![]() |
Human mastadenovirus C |
PBMC-Macrophage : 9.30% ; PBMC-T cells : 8.42% ; PBMC-NK : 7.25% ; PBMC-B cells : 1.35% ; PBMC-Neutrophil : 0.62% ; PBMC-Macrophage : 6.40% ; PBMC-T cells : 0.06% ; PBMC-NK : 0.00% ; PBMC-Macrophage : 2.91% ; PBMC-Cycling_T : 1.59% ; PBMC-B cells : 0.87% ; PBMC-T cells : 0.42% ; PBMC-Neutrophil : 0.10% ; |
![]() |
West Nile virus | |
![]() |
Coxsackievirus A9 | |
![]() |
Human parechovirus 1 | |
![]() |
Coxsackievirus B1 |
PBMC-Macrophage : 9.30% ; PBMC-T cells : 8.42% ; PBMC-NK : 7.25% ; PBMC-B cells : 1.35% ; PBMC-Neutrophil : 0.62% ; PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; PBMC-NK : 0.00% ; PBMC-Macrophage : 2.91% ; PBMC-Cycling_T : 1.59% ; PBMC-B cells : 0.87% ; PBMC-T cells : 0.42% ; PBMC-Neutrophil : 0.10% ; |
![]() |
Human gammaherpesvirus 8 |
PBMC-Macrophage : 9.30% ; PBMC-T cells : 8.42% ; PBMC-NK : 7.25% ; PBMC-B cells : 1.35% ; PBMC-Neutrophil : 0.62% ; PBMC-T cells : 0.96% ; PBMC-Macrophage : 0.58% ; PBMC-Neutrophil : 0.14% ; PBMC-B cells : 0.10% ; PBMC-Cycling_T : 0.00% ; PBMC-B cells : 0.10% ; PBMC-T cells : 0.06% ; PBMC-NK : 0.00% ; PBMC-Neutrophil : 0.00% ; |
![]() |
Echovirus E12 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; PBMC-NK : 0.00% ; |
![]() |
Echovirus E33 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; PBMC-NK : 0.00% ; |
![]() |
Coxsackievirus B5 | |
![]() |
Echovirus E7 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; |
![]() |
Echovirus E29 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; |
![]() |
Echovirus E6 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Enterovirus D68 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Echovirus E21 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Echovirus E20 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Human enterovirus 70 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Coxsackievirus B3 | |
![]() |
Echovirus E13 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; |
![]() |
Echovirus E11 |
PBMC-B cells : 9.09% ; PBMC-Neutrophil : 6.92% ; PBMC-Macrophage : 4.65% ; PBMC-T cells : 0.24% ; |
![]() |
Feline calicivirus |
PBMC-Macrophage : 7.56% ; PBMC-Cycling_T : 3.17% ; PBMC-T cells : 0.78% ; PBMC-B cells : 0.19% ; PBMC-Neutrophil : 0.05% ; |
![]() |
Encephalomyocarditis virus |
PBMC-Macrophage : 6.40% ; PBMC-B cells : 0.19% ; PBMC-Neutrophil : 0.14% ; PBMC-T cells : 0.12% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Rinderpest morbillivirus |
PBMC-T cells : 6.01% ; PBMC-B cells : 4.93% ; PBMC-Cycling_T : 3.17% ; PBMC-NK : 2.90% ; PBMC-Macrophage : 2.33% ; |
![]() |
Measles morbillivirus | |
![]() |
Phocine morbillivirus |
PBMC-T cells : 6.01% ; PBMC-B cells : 4.93% ; PBMC-Cycling_T : 3.17% ; PBMC-NK : 2.90% ; PBMC-Macrophage : 2.33% ; |
![]() |
Canine morbillivirus | |
![]() |
Jaagsiekte sheep retrovirus |
PBMC-Macrophage : 5.23% ; PBMC-B cells : 4.45% ; PBMC-T cells : 2.59% ; PBMC-Neutrophil : 0.10% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Lymphocytic choriomeningitis mammarenavirus | |
![]() |
Latino mammarenavirus |
PBMC-Cycling_T : 4.76% ; PBMC-NK : 4.35% ; PBMC-T cells : 3.61% ; PBMC-B cells : 2.22% ; PBMC-Macrophage : 1.16% ; |
![]() |
Oliveros mammarenavirus |
PBMC-Cycling_T : 4.76% ; PBMC-NK : 4.35% ; PBMC-T cells : 3.61% ; PBMC-B cells : 2.22% ; PBMC-Macrophage : 1.16% ; |
![]() |
Marburg marburgvirus | |
![]() |
Coxsackievirus B4 |
PBMC-Macrophage : 2.91% ; PBMC-Cycling_T : 1.59% ; PBMC-B cells : 0.87% ; PBMC-T cells : 0.42% ; PBMC-Neutrophil : 0.10% ; |
![]() |
Coxsackievirus B2 |
PBMC-Macrophage : 2.91% ; PBMC-Cycling_T : 1.59% ; PBMC-B cells : 0.87% ; PBMC-T cells : 0.42% ; PBMC-Neutrophil : 0.10% ; |
![]() |
Human mastadenovirus D |
PBMC-Macrophage : 2.91% ; PBMC-Cycling_T : 1.59% ; PBMC-B cells : 0.87% ; PBMC-T cells : 0.42% ; PBMC-Neutrophil : 0.10% ; |
![]() |
Coxsackievirus B6 |
PBMC-Macrophage : 2.91% ; PBMC-Cycling_T : 1.59% ; PBMC-B cells : 0.87% ; PBMC-T cells : 0.42% ; PBMC-Neutrophil : 0.10% ; |
![]() |
Human mastadenovirus A |
PBMC-Macrophage : 2.91% ; PBMC-Cycling_T : 1.59% ; PBMC-B cells : 0.87% ; PBMC-T cells : 0.42% ; PBMC-Neutrophil : 0.10% ; |
![]() |
Human mastadenovirus F |
PBMC-Macrophage : 2.91% ; PBMC-Cycling_T : 1.59% ; PBMC-B cells : 0.87% ; PBMC-T cells : 0.42% ; PBMC-Neutrophil : 0.10% ; |
![]() |
Human mastadenovirus E |
PBMC-Macrophage : 2.91% ; PBMC-Cycling_T : 1.59% ; PBMC-B cells : 0.87% ; PBMC-T cells : 0.42% ; PBMC-Neutrophil : 0.10% ; |
![]() |
Respiratory syncytial virus |
PBMC-NK : 2.90% ; PBMC-T cells : 1.20% ; PBMC-Macrophage : 1.16% ; PBMC-B cells : 0.19% ; PBMC-Neutrophil : 0.05% ; |
![]() |
Rabies lyssavirus | |
![]() |
Hepatitis E virus |
PBMC-T cells : 1.98% ; PBMC-Cycling_T : 1.59% ; PBMC-NK : 1.45% ; PBMC-Neutrophil : 0.05% ; |
![]() |
Amphotropic murine leukemia virus |
PBMC-B cells : 1.93% ; PBMC-T cells : 1.86% ; PBMC-Cycling_T : 1.59% ; PBMC-Macrophage : 0.58% ; PBMC-Neutrophil : 0.52% ; |
![]() |
Nipah henipavirus | |
![]() |
Hepatitis delta virus |
PBMC-Cycling_T : 1.59% ; PBMC-NK : 1.45% ; PBMC-B cells : 1.35% ; PBMC-Neutrophil : 1.24% ; PBMC-Macrophage : 0.58% ; |
![]() |
Hendra henipavirus | |
![]() |
Hantaan orthohantavirus |
PBMC-T cells : 0.96% ; PBMC-Macrophage : 0.58% ; PBMC-Neutrophil : 0.14% ; PBMC-B cells : 0.10% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Coxsackievirus A10 |
PBMC-Macrophage : 0.58% ; PBMC-T cells : 0.06% ; PBMC-Cycling_T : 0.00% ; |
![]() |
Zika virus |
PBMC-T cells : 0.36% ; PBMC-Cycling_T : 0.00% ; PBMC-Macrophage : 0.00% ; |
![]() |
Ross River virus |
PBMC-T cells : 0.36% ; PBMC-Neutrophil : 0.00% ; |
![]() |
Onyong-nyong virus |
PBMC-T cells : 0.36% ; PBMC-Neutrophil : 0.00% ; |
![]() |
Mayaro virus |
PBMC-T cells : 0.36% ; PBMC-NK : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Neutrophil : 0.00% ; |
![]() |
Small ruminant morbillivirus |
PBMC-B cells : 0.19% ; PBMC-Neutrophil : 0.10% ; PBMC-T cells : 0.00% ; PBMC-Cycling_T : 0.00% ; PBMC-Macrophage : 0.00% ; |
![]() |
Rhinovirus C |
PBMC-Neutrophil : 0.05% ; PBMC-NK : 0.00% ; PBMC-B cells : 0.00% ; |